Healius (ASX:HLS) is selling Lumus Imaging in a $965 million deal to pay down debt and ‘return cash to shareholders’. While subject to Foreign Investment Review Board (FIRB) approvals, the sale to Asian private equity firm, Affinity Equity Partners, is on a cash, debt and equipment-lease free basis, with net proceeds at about $800 million. 17x FY24 EBITDAHealius reported the transaction – to be finalised early 2025 – represented a multiple of 17 times FY2024 EBITDA and 25.4 FY2024 EBIT. Healius’ Managing Director & CEO Paul Anderson said it was good for shareholders, staff, patients and referr…